The present invention relates to a composition for preventing or treating diseases or symptoms associated with a reduction in the expression of peroxisome proliferator-activated receptor coactivator 1-alpha (PGC-1±), the composition comprising, as an active ingredient, a compound represented by the following general formula I, a salt thereof, or a solvate thereof.
